Correct!
5. Consider early intubation

All the drugs listed are experimental and undergoing trials (2). In our view, early intubation should be considered and non-invasive ventilation and high-flow nasal oxygen should be used sparingly (3). This is because non-invasive ventilation and high-flow nasal oxygen likely increase the infectivity of COVID-19 by aerosolizing the patient’s respiratory secretions. The patient was intubated with a limited number of people in the room in PAPR. He spent only two days receiving mechanical ventilation with a HEPA filter on the exhalational limb of the ventilator. He was extubated and rapidly improved.

References

  1. Lecrubier A. COVID-19: could hydroxychloroquine really be the answer? Medscape. March 18, 2019. Available at: https://www.medscape.com/viewarticle/927033 (accessed 3/19/20).
  2. Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther. 2020;14(1):58-60. [CrossRef] [PubMed]
  3. Raschke RA, Till SL, Luedy HW. COVID-19 prevention and control recommendations for the ICU. Southwest J Pulm Crit Care. 2020;20(3):95-7. [CrossRef]

Home/Critical Care